Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/1997
11/05/1997EP0804463A1 Neurokinine (tachykinine) antagonists
11/05/1997EP0804440A1 Tricyclic benzazepine vasopressin antagonists
11/05/1997EP0804438A1 Tricyclic benzazepine vasopressin antagonists
11/05/1997EP0804425A2 Benzodiazepine derivatives
11/05/1997EP0804419A1 Quinoline derivatives as tachykinin nk 3 receptor antagonists
11/05/1997EP0804248A2 Chemically modified interferon
11/05/1997EP0804239A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
11/05/1997EP0804196A1 Use of serotonin antagonists (5ht 3?) for treating fibromyalgia
11/05/1997EP0804192A1 Pharmaceutical preparations for tumour necrosis factor (tnf) inhibition
11/05/1997EP0804184A1 USE OF $g(v)-GUANIDINOCARBOXYLIC ACID ESTERS
11/05/1997EP0804170A2 Method for making freeze dried drug dosage forms
11/05/1997EP0804152A1 Lactulose lozenges
11/05/1997CN1164233A Enterokinetic benzamide
11/05/1997CN1163776A Medicine for treating hepatic disease
11/04/1997US5684205 Use of substituted cyclopentane- di- and -triones
11/04/1997US5684034 1H-indole-3-acetamide sPLA2 inhibitors
11/04/1997US5684033 Antiarthritic agents, analgesics and migraine
11/04/1997US5684014 Cycloalkano-indole and -azaindole derivatives
11/04/1997US5683873 EGS-mediated inactivation of target RNA
11/04/1997US5683865 Method for diagnosis of mystery swine disease
11/04/1997CA2083698C (+)-alpha-(2,3-dimethoxyphenyl)-1- [2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
10/1997
10/30/1997WO1997040066A1 Suppression of immune response via inhibition of cathepsin s
10/30/1997WO1997040045A1 Heterocyclic compounds and their preparation and use
10/30/1997WO1997040044A1 Heterocyclic compounds
10/30/1997WO1997040043A1 Heterocyclic compounds
10/30/1997WO1997040042A1 Heterocyclic compounds
10/30/1997WO1997040031A1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors
10/30/1997WO1997040016A1 Heterocyclic compounds
10/30/1997WO1997039768A1 A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent
10/30/1997WO1997006255A3 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
10/30/1997CA2252563A1 Heterocyclic compounds and their preparation and use
10/30/1997CA2252527A1 Heterocyclic compounds
10/30/1997CA2251974A1 Heterocyclic compounds
10/30/1997CA2251714A1 Suppression of immune response via inhibition of cathepsin s
10/30/1997CA2250873A1 Heterocyclic compounds
10/30/1997CA2250472A1 Heterocyclic compounds
10/29/1997EP0803501A1 Substituted guanidine derivatives and their use as Na+/H+ exchange inhibitors
10/29/1997EP0802976A2 Stabilized external guide sequences
10/29/1997EP0802972A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
10/29/1997EP0802922A1 Novel amino acid derivatives, method of producing them and pharmaceutical compositions containing these compounds
10/29/1997EP0802912A1 Piperidine derivatives having tachykinin antagonist activity
10/29/1997EP0802908A1 Novel compounds
10/29/1997EP0802897A1 Novel compounds
10/29/1997EP0637976B1 Medicament for disinfection of the oral cavity
10/29/1997EP0493380B1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
10/29/1997EP0471756B1 Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
10/29/1997CN1163656A Axial flow valve system for linear compressor
10/29/1997CN1163143A Medicine powder for curing hepatitis B
10/29/1997CN1163142A Medicine for curing peptic ulcer
10/29/1997CN1163120A Medicine for curing tooth-ache and its preparation
10/28/1997US5681833 Benzodiazepine derivatives
10/28/1997US5681827 Aqueous pourable liquid containing low viscosity sodium alginate, potassium bicarbonate
10/28/1997US5681590 Dry mix formulation for bisphosphonic acids
10/28/1997CA2136825C Quaternary nitrogen-containing phosphonate compounds, for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque
10/23/1997WO1997039031A1 Glucagon-like peptide-2 analogs
10/23/1997WO1997039001A1 Isoxazolidine derivatives
10/23/1997WO1997038991A1 Substituted tetracyclic tetrahydrofuran derivatives
10/23/1997WO1997038986A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
10/23/1997WO1997038726A2 Hydrophobic carbomer complex compositions
10/23/1997WO1997038724A1 New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
10/23/1997WO1997038712A1 Intestinal trefoil proteins
10/23/1997WO1997038690A1 Agent for inhibiting leukocyte invasion of tissues
10/23/1997CA2251849A1 Hydrophobic carbomer complex compositions
10/23/1997CA2251631A1 Intestinal trefoil proteins
10/22/1997EP0802196A1 Alkylenediamine derivative, antiulcer drug, and antibacterial drug
10/22/1997EP0801951A2 Novel uses of Il-4 and/or Il-10, and antibodies against the same
10/22/1997EP0801656A1 Induction of cytotoxic t-lymphocyte responses
10/22/1997EP0801570A1 Formulations and methods for reducing skin irritation
10/22/1997EP0801554A1 Formulations and methods for reducing skin irritation
10/22/1997EP0681583B1 Tricyclic heterocyclic compounds as 5-ht4 receptor antagonists
10/22/1997EP0646586B1 2-aminoethanesulfonic acid/zinc complex compound
10/22/1997EP0640080B1 Substituted indoles as angiotensin ii antagonists
10/22/1997CN1162485A Medicine for curing bilestone and biliary calculus
10/22/1997CN1162480A Powder for curing hepatitis
10/22/1997CN1162453A Kouyangning lozenge
10/22/1997CN1162449A Medical composition for gastritis and ulcer
10/22/1997CN1036199C Erythromycin derivatives
10/21/1997US5679717 Method for removing bile salts from a patient with alkylated amine polymers
10/21/1997US5679711 Hydroxyl ions as novel therapeutic agents and compounds that modulate these ions, compositions employing these agents, therapeutic methods for using such agents
10/21/1997US5679700 Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents
10/21/1997US5679339 Method of using IL-11 for treating spondyloarthropies
10/18/1997CA2202958A1 Alkylenediamine derivative, anti-ulcer drug, and antibacterial drug
10/16/1997WO1997038007A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
10/16/1997WO1997038002A1 Extracellular/epidermal growth factor-like protein
10/16/1997WO1997037974A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/16/1997WO1997037973A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/16/1997WO1997037681A1 Medicament for optimising mucosal viscosity and stimulating intestinal function
10/16/1997WO1997037666A1 Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents
10/16/1997WO1997037658A1 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents
10/16/1997WO1997024125A3 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol
10/16/1997CA2251009A1 Medicament for optimising mucosal viscosity and stimulating intestinal function
10/16/1997CA2250898A1 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents
10/16/1997CA2249213A1 Extracellular/epidermal growth factor-like protein
10/16/1997CA2248082A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
10/16/1997CA2248070A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/16/1997CA2247964A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/15/1997EP0801132A2 Staphylococcal FtsH protein
10/15/1997EP0801067A1 Novel quinuclidine derivatives and medicinal composition thereof
10/15/1997EP0801060A1 Heterocyclic Beta-3 Adrenergenic Agonists
10/15/1997EP0800534A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases